Starling Oncology, Inc.
Status: Publicly traded
Direct answer
Starling Oncology, Inc. is publicly traded on NASDAQ under the ticker STLN.
Starling Oncology, Inc., formerly The Oncology Institute, is a value-based oncology company advancing cancer care in the community setting. Founded in 2007, the company offers cutting-edge, evidence-based cancer treatments, including clinical trials and transfusions, to a large patient population. It operates as an integrated oncology platform serving patients, providers, and health plans across multiple markets...
Can you invest in Starling Oncology, Inc.?
Yes. Starling Oncology, Inc. trades publicly on NASDAQ as STLN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Starling Oncology, Inc.
Detailed equity research is provided by MarketSnap.